U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
6570165701Open Label Extension Study of STX209 (Arbaclofen) in Autism Spectrum DisordersTerminatedNo Results AvailableAutism Spectrum DisordersDrug: STX209 (arbaclofen)https://ClinicalTrials.gov/show/NCT01706523
6570265702Antiplatelet Effects of Ticagrelor Versus Clopidogrel in American Indian PatientsCompletedNo Results AvailableCoronary Artery DiseaseDrug: Ticagrelor|Drug: Clopidogrelhttps://ClinicalTrials.gov/show/NCT01706510
6570365703Predictive Value of the FORE-SIGHTâ„¢ Monitor for Hemodynamic DeteriorationRecruitingNo Results AvailablePediatric Congenital Heart SurgeryDevice: Cerebral tissue oxygen saturation monitoring, blindedhttps://ClinicalTrials.gov/show/NCT01706497
6570465704Efficacy and Safety of Two Dosages of a Herbal Medicinal Product (Dry Extract BNO 1016) in Chronic RhinosinusitisCompletedNo Results AvailableChronic SinusitisDrug: BNO 1016https://ClinicalTrials.gov/show/NCT01706484
6570565705Safety and Efficacy of the Early Introduction of Everolimus (Certican®) With Low Dose of Cyclosporine in de Novo Kidney Recipients After 1 Month of TransplantationCompletedNo Results AvailablePlanned Kidney TransplantationDrug: Everolimus + Low dose CsA +PD|Drug: Myfortic+ Standard CsA + PDhttps://ClinicalTrials.gov/show/NCT01706471
6570665706Provenge With or Without pTVG-HP DNA Booster Vaccine in Prostate CancerRecruitingNo Results AvailableProstate CancerBiological: sipuleucel-T|Biological: DNA Vaccinehttps://ClinicalTrials.gov/show/NCT01706458
6570765707Combined Inspiratory Muscle and 'Whole Muscle' Training in Children With Cystic FibrosisCompletedNo Results AvailableCystic FibrosisOther: Otherhttps://ClinicalTrials.gov/show/NCT01706445
6570865708Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast CancerActive, not recruitingNo Results AvailableCentral Nervous System Metastases|Invasive Ductal Breast Carcinoma|Invasive Ductal Breast Carcinoma With Predominant Intraductal Component|Invasive Lobular Breast Carcinoma|Invasive Lobular Breast Carcinoma With Predominant in Situ Component|Liver MetastaRadiation: hyperfractionated radiation therapy|Other: laboratory biomarker analysis|Radiation: stereotactic radiosurgeryhttps://ClinicalTrials.gov/show/NCT01706432
6570965709Fortified Rice for School Children in CambodiaCompletedNo Results AvailableMicronutrient StatusDietary Supplement: Fortified rice cold extruded kernel|Dietary Supplement: fortified rice warm extruded kernel|Dietary Supplement: fortiified rice hot extruded kernelhttps://ClinicalTrials.gov/show/NCT01706419
6571065710Group Psychoeducational Treatment for Women With Sexual Arousal Difficulties, Phase IICompletedNo Results AvailableLow Female Sexual Arousal|Low Female Sexual DesireBehavioral: Brief psychoeducational intervention for female sexual arousal disorderhttps://ClinicalTrials.gov/show/NCT01706406
6571165711Effects of Probiotics Supplementation on Intestinal Microbiome in Malignancy Pts(Get Pelvic/Abdominal Rtx)RecruitingNo Results AvailableCancerDietary Supplement: probiotics (six probiotic cultures)|Dietary Supplement: Placebohttps://ClinicalTrials.gov/show/NCT01706393
65712657123M Study - Maria Malmö Mobile Telephone StudyRecruitingNo Results AvailableSubstance Use DisordersBehavioral: Interactive voice response with personal feedback|Behavioral: Interactive voice response without personal feedbackhttps://ClinicalTrials.gov/show/NCT01706380
6571365713Evaluation of a 3-dose Vaccination Regimen With One of Three Ascending Dose Levels of Clostridium Difficile Vaccine With or Without Adjuvant in Healthy Adults Aged 50 to 85 YearsCompletedNo Results AvailableClostridium Difficile Associated DiseaseBiological: C. difficile vaccine|Biological: C. difficile vaccine +adjuvant|Biological: C. difficile vaccine|Biological: C. difficile vaccine +adjuvant|Biological: C. difficile vaccine|Biological: C. difficile vaccine +adjuvanthttps://ClinicalTrials.gov/show/NCT01706367
6571465714Local Anaesthesia vs Regional Block for Arteriovenous FistulaeRecruitingNo Results AvailableEnd Stage Renal DiseaseProcedure: Local Anaesthetic|Procedure: Regional anaesthetichttps://ClinicalTrials.gov/show/NCT01706354
6571565715The Effect of Administering a Small Dose of Glucose During Cesarean SectionRecruitingNo Results AvailableCesarean SectionDrug: administer acetate Ringer's solution|Drug: acetate Ringer's solution containing no glucose|Drug: acetate Ringer's solution containing 1% glucosehttps://ClinicalTrials.gov/show/NCT01706341
6571665716A Study to Assess the Efficacy of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25 mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50 mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary DiseasCompletedHas ResultsPulmonary Disease, Chronic ObstructiveDrug: FF/VI 100/25 Inhalation Powder NDPI|Drug: Fluticasone Propionate/Salmeterol 250/50 Inhalation Powder ACCUHALER/DISKUS|Drug: Placebo Inhalation Powder NDPI|Drug: Placebo Inhalation Powder ACCUHALER/DISKUS|Drug: Salbutamol as neededhttps://ClinicalTrials.gov/show/NCT01706328
6571765717This Study Will Investigate the Safety, Tolerability and Pharmacokinetic Profile of Repeat Oral Doses of GSK2140944 in Healthy Adult SubjectsCompletedNo Results AvailableInfections, Respiratory TractDrug: GSK2140944|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01706315
6571865718Burden of Respiratory Syncytial Virus (RSV) in the United Kingdom From 1995 to 2009CompletedNo Results AvailableRespiratory Syncyctial Virus VaccinesOther: Data collectionhttps://ClinicalTrials.gov/show/NCT01706302
6571965719The Relationship Between Vascular Adhesion Protein-1 and Diabetic Cardiovascular Autonomic NeuropathyRecruitingNo Results AvailableNeuropathy; Peripheral, Autonomic, in Diabetes Mellitus (Manifestation)https://ClinicalTrials.gov/show/NCT01706289
6572065720MASIMO Radical 7 and Laboratory MeasurementCompletedNo Results AvailableMajor Hepatic Surgeryhttps://ClinicalTrials.gov/show/NCT01706276
6572165721U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With AcneCompletedNo Results AvailableAcne VulgarisOther: MAXCLARITY II (2.5% BPO) Foam Cleanser|Other: MAXCLARITY II (2.5% BPO) Foam Treatment|Other: MAXCLARITY II (0.5% Salicylic Acid) Toner Foamhttps://ClinicalTrials.gov/show/NCT01706263
6572265722U0289-401: Eight Week, Split-face, Study to Determine and Compare the Efficacy and Tolerability of MAXCLARITYâ„¢ II to PROACTIVâ„¢CompletedNo Results AvailableAcne VulgarisOther: MAXCLARITY II (2.5% BPO) Foam Cleanser|Other: MAXCLARITY II (2.5% BPO) Foam Treatment|Other: MAXCLARITY II (0.5% Salicylic Acid) Toner Foam|Other: PROACTIV (2.5% BPO) Renewing Cleanser|Other: PROACTIV (2.5% BPO) Repairing Lotion|Other: PROACTIV (2.5% BPO) Revitalizing Tonerhttps://ClinicalTrials.gov/show/NCT01706250
6572365723Visual Outcomes And Contrast Sensitivity After Myopic Wavefront-Optimized Lasik With Nexisvision Shield Or Bandage Contact LensWithdrawnNo Results AvailableMyopiaDevice: Nexisvision shieldhttps://ClinicalTrials.gov/show/NCT01706237
6572465724Sero-prevalence of Anti-pertussis Antibodies and Disease Awareness Among Spanish Healthcare ProfessionalsCompletedNo Results AvailablePertussisProcedure: Blood sample|Other: Data collection|Other: Data collectionhttps://ClinicalTrials.gov/show/NCT01706224
6572565725A Study to Evaluate the Efficacy and Safety of BRL 49653C in Non-insulin Dependent DiabetesCompletedNo Results AvailableDiabetes Mellitus Non Insulin Dependent Oral Agent TherapyDrug: BRL 49653C|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01706211
6572665726An Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in AsthmaRecruitingNo Results AvailableAsthmaDrug: fluticasone furoate + vilanterol|Drug: inhaled corticosteroid with or without a long acting beta2-agonisthttps://ClinicalTrials.gov/show/NCT01706198
6572765727Incidence of Expression of Tumor Antigens in Cancer Tissue From Patients With Pathologically Demonstrated Bladder CancerCompletedNo Results AvailablePathologically Demonstrated Bladder CancerOther: Data acquisition and analysishttps://ClinicalTrials.gov/show/NCT01706185
6572865728Treatment of Temporomandibular Dysfunction With Hypertonic Dextrose InjectionActive, not recruitingNo Results AvailableTemporomandibular Joint DisordersOther: Injection of 20% dextrose/ 0.2% lidocaine|Other: Injection of 1 ml of 0.8 Sterile water /0.2% lidocainehttps://ClinicalTrials.gov/show/NCT01706172
6572965729A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative ColitisTerminatedHas ResultsInflammation|Ulcerative ColitisDrug: catridecacog|Drug: placebohttps://ClinicalTrials.gov/show/NCT01706159
6573065730Rhythm Evaluation for AntiCoagulaTion With COntinuous MonitoringCompletedNo Results AvailableAtrial FibrillationDrug: Non-coumadin Oral Anticoagulanthttps://ClinicalTrials.gov/show/NCT01706146

* Görseller ve İçerik tekif hakkına sahip olabilir